Circassia Pharmaceuticals PLC

(LSE, Stocks) 
Industry: Financials seperator Sector: General Finance
p 71.40 <%= Resources.Global.txtDown %>
Updated 18:45:04
Change % -5.68% Stock price decreasing
Change -4.30 Stock price decreasing
Volume 24,224
High P 76.20
Low P 71.40
Open P 75.60
Prev close P 75.70
# of shares 357.23M
Market cap 25,506M GBX

Market closed
Circassia Pharmaceuticals PLC
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  71.40 -3.9% Stock price decreasing -7.8% Stock price decreasing -20.7% Stock price decreasing -17.8% Stock price decreasing -15.0% Stock price decreasing
Powered by TradingView

Company profile

Circassia Pharmaceuticals PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has three business segments, US AZ collaboration, Respiratory, and NIOX. The clear majority of revenue is generated by sales in the United States and European Union, followed by other international locations. The bulk of revenue is derived from Circassia's NIOX segment, which is focused on the diagnosis and management of asthma. The company sells its NIOX products direct to specialists in the U.S, U.K and Germany, while its partners market them elsewhere.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
24 September 2018 21:11:26
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB3 - 2018-09-24 22:11:26 - 2018-09-24 21:11:26 - 1000 - Website: OKAY